Entity
  • BIOTECHFINANCES

    Created in 1999
  • Social networks

    4,760 3,672
  • Entity types

  • Location

    12 Rue Cavenne, 69007 Lyon, France

    Lyon

    France

  • Employees

    Scale: 2-10

    Estimated: 9

  • SIREN

    480764398
  • Engaged corporates

    13
    4 3
  • Added in Motherbase

    4 years, 3 months ago
Description
  • Value proposition

    [Automatic translation follows] 1st weekly specialist information, biotech, medtech, e-health, finance published by Jacques Bernard Taste

    PRESENTATION
    The weekly Biotech Finances letter approaches from an economic and financial angle all questions linked to the development of the biotechnology sector and more broadly life sciences. Our target readership is mainly composed of biotechnology companies focused on health and the development of new therapies and new treatments for diseases, pharmaceutical companies (big pharma and other laboratories), investors, business angels, funds investments, venture capital, specialists in the biotech sector, institutional investors, legal advisors, development experts, and service providers and equipment suppliers. Our articles deal with research and development, new products, drugs, molecules, clinical and preclinical trials with their different phases, financing and financial practices, fundraising, capital increases, equity investments, IPOs (introductions in stock market) of industrial property, patents, approvals in Europe (EMEA) and the United States (FDA), partnerships, co-development, licensing (in licensing / out licensing) which allow the development and growth of biotech companies .

    finance, biotech, France, SPECIALIZED PRESS, biotechnology, healthtech, medtech, pharmaceutical, medical, conference, interviews, news, investors, startups, investments, and start-ups

  • Original language

    1er hebdomadaire d'informations spécialisées, biotech, medtech, e-santé, finances publié par Jacques Bernard Taste

    PRESENTATION
    La lettre hebdomadaire Biotech Finances approche sur un angle économique et financier toutes les questions liées au développement du secteur des biotechnologies et plus largement des sciences de la vie. Notre lectorat cible est composé en majeure partie d'entreprises de biotechnologies orientées sur la santé et le développement de nouvelles thérapies et de nouveaux traitement de maladies, d'entreprises pharmaceutiques (big pharma et autres laboratoires) , d'investisseurs, business angel , fonds d'investissements, capital risque, spécialisés dans le secteur des biotech, d'institutionnels, de conseils juridiques, d'experts en développement, et de fournisseurs de services et fournisseurs de matériels. Nos articles traitent de recherche et développement, de nouveaux produits, médicaments, molécules, essai clinique et préclinique avec leur différentes phases, de financements et pratiques financières, de levées de fonds, augmentation de capital, prise de participations, d'IPO (introductions en bourse) de propriété industrielle, brevets, agréements en Europe (EMEA) et aux Etats-Unis (FDA), de partenariats, co-développement, licensing (in licensing /out licensing) qui permettent l'épanouissement et la croissance des sociétés de biotech.

    finance, biotech, france, PRESSE SPECIALISEE, biotechnologie, healthtech, medtech, pharmaceutique, médical, conférence, interviews, actualité, investisseurs, startups, investissements, and start-up

  • Biotech Finances

    Biotech Finances est un média spécialisé dans l'information financière et économique de l'industrie biopharmaceutique en France et en Europe. Il fournit des analyses approfondies sur les tendances du marché, les fusions et acquisitions, les financements et les partenariats dans le secteur de la biotechnologie.

  • https://biotech-finances.com/
Corporate interactions BETA
Corporate TypeTweets Articles
SATT Nord SATT Nord
Other

28 Feb 2024


Cathay Innovation
Cathay Innovation
Startup accelerator & VC, Venture Capital and Private Equity Principals
Cathay Innovation
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

4 Sep 2023


Karista
Karista
Startup accelerator & VC, Venture Capital and Private Equity Principals
Karista
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

16 Mar 2023


Leem
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Other

9 Jun 2020


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

29 Apr 2024


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

26 Jun 2017

24 Mar 2024



Institut Analgesia
Institut Analgesia
Research, Think Tanks
Institut Analgesia
Research, Think Tanks
Other

28 Sep 2015


Linksium
Linksium
Venture Capital and Private Equity Principals
Linksium
Venture Capital and Private Equity Principals
Other

26 Jun 2019

29 Sep 2023



Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Other

19 Oct 2023


Eurasanté
Eurasanté
Startup accelerator & VC, Biotechnology, Biotechnology Research
Eurasanté
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

28 Feb 2024


Similar entities
Loading...
Loading...
Social network dynamics